Cardano (ADA-USD)
$0.16
$1.32
-87.7%
Stage 4 (Downtrend)
Bullish factors: MACD+
Bearish factors: price < 50d, price < 200d, death cross, 50d falling, far below high
Low: $0.14
Now: $0.16
Technical Snapshot
| RSI (14) | 46.0 | ADX (14) | 16.1 |
| 50d MA | $0.17 | 200d MA | $0.25 |
| Price vs 50d | ▼ Below | Price vs 200d | ▼ Below |
| Support | $0.14 | Resistance | $0.20 |
| ATR Volatility | 5.15%/day | Trend | SELL |
Crypto Performance Comparison
| Asset | 1 Month | 3 Months | 6 Months | 1 Year |
| ADA-USD | +11.8% | -35.3% | -38.0% | -70.8% |
| BTC | +6.8% | -16.6% | -8.6% | -37.7% |
| ETH | +15.6% | -12.5% | -9.3% | -45.5% |
| SOL | +1.6% | -10.7% | -12.0% | -50.7% |
Trend-Following Backtest
2-year simulation of 35,000 using 50d/200d MA crossover + RSI filter. Buy when price > 50d MA (rising) + RSI 40-75. Sell on death cross or RSI > 82.
Strategy vs Buy & Hold
| Asset | Strategy | Buy & Hold | Max DD | Trades | Win Rate |
| ADA-USD | -45.7% | -77.8% | -45.7% | 28 | 32% |
DCA vs Lump Sum (ADA-USD)
If you had deployed 35,000 using different timing strategies over the past year.
| Strategy | Return | Value Today |
| Lump Sum (1y ago) | -70.8% | $6,395 |
| DCA — 4 buys | -61.9% | $13,325 |
| DCA — 6 buys | -60.7% | $13,751 |
| DCA — 12 buys | -55.0% | $15,744 |
ADA-USD Deployment Plan — 35,000 Portfolio
Analysis by Oliver Schmidt (Conservative / Institutional). If you’re managing a 35,000 crypto allocation, here’s the plan:
| Position size | $5,250 (15% of portfolio) |
| Stop loss | $0.15 (-10.3%) |
| Target 1 | $0.00 (-100.0%) |
| Target 2 | $0.00 (-100.0%) |
| Entry quality | Pullback |
| Max concurrent positions | 10 |
Cash reserve: keep 15% buffer. Deploy in 3 tranches. Portfolio style: Conservative / Institutional.
Backtest Trade Log
| Date | Action | Price | P&L |
| 2025-08-08 | BUY | 0.79 | |
| 2025-08-09 | SELL | 0.80 | +1.6% |
| 2025-08-10 | BUY | 0.80 | |
| 2025-08-11 | SELL | 0.77 | -3.5% |
| 2025-08-12 | BUY | 0.84 | |
| 2025-08-31 | SELL | 0.81 | -3.5% |
| 2025-09-02 | BUY | 0.83 | |
| 2025-09-04 | SELL | 0.81 | -3.0% |
| 2025-09-05 | BUY | 0.83 | |
| 2025-09-06 | SELL | 0.82 | -1.5% |
| 2025-09-07 | BUY | 0.84 | |
| 2025-09-22 | SELL | 0.83 | -1.1% |
Trend-following methodology: 50d/200d MA crossover + RSI filter + ADX regime gate
Data via Yahoo Finance / CoinGecko · Not financial advice. For educational purposes only.
87.7% drawdown on ADA and only 1 bullish factor (MACD+). charles really promised africa and delivered a 16 cent token
been holding ada since $2.40, this report is validating what i refused to accept for 2 years lol
the 2.40 holders are the saddest club in crypto. nobody sells at 16 cents but nobody should pretend the thesis survived either. its sunk cost with extra steps
-87.7% from the high. $0.16. and people on CT still posting Charles Hoskinson rainforest videos like everything is fine. brutal
ada_cope_denier 87.7pct drawdown and people still posting Charles videos like peer reviewed research moves price. ADA at 16 cents is the market voting on the thesis
ada_cope_denier 87.7pct drawdown and charles is still posting hour long youtube videos from his farm. the peer reviewed research approach produced zero products people actually use
1 bull factor out of 6 total. thats a pretty strong sell signal even for the ADA faithful. been saying the peer reviewed research angle doesnt save you from price action
the fact that its stage 4 downtrend with a death cross AND 50d falling makes this an easy skip. even ETH maxis feel bad for ADA bagholders at this point
input_end_ MACD bullish crossover in a stage 4 downtrend is a dead cat bounce signal not a reversal. anyone buying ADA here is catching a falling knife
input_end_ stage 4 downtrend with death cross and 50d falling is the textbook definition of do not catch this knife. ada at 16 cents might still be expensive if the thesis is broken
35k portfolio deployment plan on a SELL rating is interesting framing. assume this is risk management not investment advice, but someone out there is definitely ignoring the red banner
ruby_slate_ or the analyst gets paid either way. SELL rating with a deployment plan is just hedging your own credibility
35k deployment plan paired with a SELL rating is confusing signaling. either the analysis is wrong or someone is buying a bag they told you to avoid
ruby_slate_ 35k deployment on a SELL rating is actually wild. either the analyst is hedging or the portfolio strategy is completely disconnected from the rating. pick one
ruby_slate_ 35k deployment on a SELL rating makes sense if its a hedged position or paired with options. not every size is a conviction long
ADA at 16 cents after 87 pct drawdown and people still debate whether its cheap. a token can always go to zero, ask LUNA holders
LUNA died because it was collateralized by its own token. ADA is dull but the mechanic is different, a slow bleed can recover, a death spiral cant
true but slow bleed has its own endgame. protocols rarely die, they stop shipping and the treasury follows. commit activity tells that story faster than any chart
recover to what tho. 50d sitting at 0.17 and falling, every bounce since 0.56 has been a lower high. slow bleed still ends at zero if nothing arrests it, luna just got there faster
the part nobody prices is carry. staking at ~3 pct on a bag down 87 pct means you needed a full cycle just to claw back to even. that yield is a sedative, the dilution never sleeps
35K deployment plan is brutal but honest. ADA at 0.42 with that staking dilution curve means bags get heavier every epoch whether you like it or not
stake_void_ the dilution math is what kills me. everyone focuses on price but effective ADA per staker drops every epoch. compounding losses
rewards paid in a token down 87 pct is just slower bleed. the epoch math only works if the price floor holds
A SELL rating paired with a 35k deployment plan is the analyst hedging in both directions. Publish one number you actually believe
the plan is a template they run on every ticker, 35k is the model size not a recommendation. still agree the SELL label next to a deployment plan reads like hedging both outcomes